Notably, the GPR84+ cell frequencies in peripheral blood from patients with esophageal squamous cell cancer (ESCC) and non-small cell lung cancer (NSCLC) were significantly higher than those in samples from healthy controls (Fig. 4a). This evidence concerns the gene GPR84 and esophageal squamous cell carcinoma.